Figure 4. The effect of miR-130 and Runx3 on EPC differentiation.

Expression of CD64 and vWF were analyzed by flow cytometry. (A, B) Cells were transfected with a miR-130 inhibitor or both miR-130 inhibitor and lentiviral Runx3. (C, D) cells were transfected with lentiviral miR-130 or both lentiviral miR-130 and lentiviral vector expressing Runx3 shRNA (Runx3-SH). Lenti-V: cells were tranfected with an empty vector. *P<0.05 vs. respective Lenti-V groups. #P<0.05 vs. healthy control group. Similar results were obtained in at least three separate experiments and error bars represent the standard deviation from the mean.